Trial Profile
Trial to Confirm the Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2020
Price :
$35
*
At a glance
- Drugs Botulinum toxin B (Primary)
- Indications Systemic scleroderma; Ulcer
- Focus Therapeutic Use
- 10 May 2020 Status changed from active, no longer recruiting to completed.
- 18 Feb 2018 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2018.
- 18 Feb 2018 Status changed from recruiting to active, no longer recruiting.